Articles · Symptoms
Restless Legs in Perimenopause
How iron, dopamine, and estrogen combine to disrupt your sleep.
Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.
Restless legs syndrome (RLS) is a neurological condition: an uncomfortable urge to move the legs, usually worst in the evening and at rest, and partly or fully relieved by movement. It is more common in women than men, and its rate rises during pregnancy and at menopause, both periods of major hormonal change. For many perimenopausal women, RLS either begins or worsens at this stage, and clinicians rarely connect it to the transition.
The connection is mechanistic, and it matters: RLS is a significant driver of sleep disruption that compounds every other perimenopausal symptom it accompanies.
What RLS Feels Like
The sensation varies between people. Common descriptions include crawling, creeping, tingling, pulling, or an irresistible itch deep inside the legs that cannot be scratched. In most cases it is not painful in the usual sense, though severe cases can be. It affects both legs in most people, though one may be worse. It is consistently worse in the evening and when lying down, which is why it directly interferes with falling asleep.
Many women with RLS also have periodic limb movements of sleep (PLMS): involuntary leg jerks or kicks during sleep that may wake them or their partner. These can happen without the conscious sensation of RLS and are confirmed by a sleep study.
The Dopamine Connection
The main physiological mechanism of RLS involves dopamine pathways in the central nervous system, particularly the A11 pathway, which runs from the hypothalamus down the spinal cord and sets sensory and motor thresholds in the limbs.[1]
Dopamine function in this pathway follows a daily rhythm, peaking in the morning and falling in the evening. This directly explains why RLS is worst at night: dopamine’s damping of sensory signals is at its lowest in the evening. When this system is already compromised, by iron deficiency, genetics, or hormonal changes, the evening low point produces symptoms.
Estrogen influences dopamine synthesis, transport, and receptor sensitivity. Animal studies have shown that estrogen increases dopamine availability in several brain regions, and that estrogen withdrawal reduces dopamine function.[2] That gives a plausible mechanism for why RLS onset or worsening tracks the estrogen swings of perimenopause.
Iron and Its Central Role
Iron deficiency is the most clearly established correctable risk factor for RLS, even without anemia. Iron is a cofactor for tyrosine hydroxylase, the enzyme that converts tyrosine to L-DOPA in the dopamine synthesis pathway. Low brain iron reduces the capacity to make dopamine, worsening the dopamine deficit that underlies RLS.[3]
The measure that matters is brain iron status, not blood iron. The blood-brain barrier creates a compartment in which brain iron can be low while serum ferritin looks normal. Research by Allen et al. has established that a serum ferritin below 75 mcg/L (some guidelines use 50 mcg/L) is associated with RLS even in patients without anemia, and that iron supplementation in this range produces clinically meaningful improvement in RLS severity.[4]
Standard NHS testing for anemia uses a threshold of 12 to 13 mcg/L for ferritin. A result that comes back as “normal” by anemia criteria may still represent iron insufficiency from an RLS point of view. If you have RLS symptoms, ask specifically for ferritin and request the numerical result, not just a “normal/abnormal” reading.
Why Perimenopause Raises Risk
Several factors converge to explain the peak in RLS during perimenopause:
Estrogen decline and dopamine. Falling estrogen reduces dopamine tone in pathways that regulate sensory processing in the limbs.
Iron status changes. Perimenopausal women may have built up iron depletion from years of menstruation. As cycles become irregular and then stop, the ongoing menstrual iron drain ends, but women who enter perimenopause with low-normal ferritin carry that deficit forward. Lower estrogen also reduces gut iron absorption.[5]
Sleep disruption feedback. Sleep loss itself worsens RLS severity, because sleep is when dopamine systems restore function. Hot-flash-disrupted sleep in perimenopause creates a cycle in which poor sleep worsens RLS, which further disrupts sleep.
Magnesium deficiency. Low magnesium, common in midlife women and worsened by estrogen decline, is linked to both muscle cramps and RLS. Magnesium has a damping effect on NMDA receptors that, when absent, may increase excitatory signaling in limb sensory pathways.[6]
Diagnosis
RLS is a clinical diagnosis based on four essential criteria, often abbreviated as URGE:
- Urge to move the legs
- Rest induced (symptoms are worse at rest)
- Gets better with movement
- Evening and nighttime predominance
These four criteria, confirmed by history, are enough for diagnosis. No imaging or electrical test is required. A doctor can diagnose RLS.
Before treating, it is worth ruling out secondary causes and correctable contributors:
- Full blood count and serum ferritin (with the numerical result)
- Kidney function (chronic kidney disease is a strong risk factor for RLS)
- Thyroid function (hypothyroidism can cause or worsen RLS)
- Glucose (diabetes and nerve damage can mimic RLS)
Medication review matters too. Several common medications worsen RLS: antihistamines (including those in over-the-counter sleep aids), anti-nausea drugs (metoclopramide, prochlorperazine), antidepressants (SSRIs, tricyclics), and antipsychotics. If any of these are being taken, discussing alternatives with the prescriber is worth considering.
What Actually Helps
Iron supplementation is the first step if ferritin is below 75 mcg/L. Oral ferrous sulphate or ferrous fumarate taken on an empty stomach (or with vitamin C, which improves absorption) for 3 to 6 months is standard. Retesting ferritin at 3 months confirms the response. RLS symptom improvement often lags the ferritin increase by 4 to 8 weeks.
Magnesium at 300 to 400 mg glycinate or citrate at bedtime has shown benefit in RLS in small trials, with a plausible mechanism and good tolerability. A reasonable add-on alongside iron correction.[6]
Sleep hygiene targeted at RLS. Keeping legs cool at bedtime (cool room, light bedding), leg stretching or massage before bed, and avoiding triggers such as caffeine, alcohol, and sedating antihistamines, to reduce symptom severity in the vulnerable evening window.
Aerobic exercise during the day (not too close to bedtime) consistently reduces RLS severity in controlled trials, likely through its effects on dopamine function and iron use in muscle.[7]
HRT. Several observational studies and case series have found improvement in RLS symptoms in perimenopausal women after starting estrogen therapy, consistent with the dopamine mechanism.[8] This is not a licensed use for HRT and the evidence is observational rather than from randomized trials, but it adds to the potential benefits for women considering HRT for other reasons.
Prescription treatment. When lifestyle and iron correction are not enough, first-line drug treatment for RLS in the UK includes dopamine agonists (pramipexole, ropinirole) at low doses, and pregabalin or gabapentin. These are effective but carry side-effect profiles that need consideration; dopamine agonists in particular carry augmentation risk (the paradoxical worsening of RLS over time). A doctor or neurologist prescribes these; they are not available over the counter.
References
[1] Clemens, S., Rye, D., Hochman, S. (2006). Restless legs syndrome: Revisiting the dopamine hypothesis from the spinal cord perspective. Neurology, 67(1), 125–130. https://doi.org/10.1212/01.wnl.0000223316.53428.c9
[2] Weick, B. G., Bhansali, P., Bhansali, S., Solberg, R. A. (1993). Estrogen effects on dopamine synthesis: Influence on L-DOPA and ergot alkaloid interactions. Journal of Pharmacology and Experimental Therapeutics, 266(2), 767–773.
[3] Connor, J. R., Ponnuru, P., Wang, X. S., Patton, S. M., Allen, R. P., Earley, C. J. (2011). Profile of altered brain iron acquisition in restless legs syndrome. Brain, 134(4), 959–968. https://doi.org/10.1093/brain/awr012
[4] Allen, R. P., Auerbach, S., Bahrain, H., Auerbach, M., Earley, C. J. (2013). The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia. American Journal of Hematology, 88(4), 261–264. https://doi.org/10.1002/ajh.23397
[5] Hercberg, S., Preziosi, P., Galan, P. (2001). Iron deficiency in Europe. Public Health Nutrition, 4(2B), 537–545. https://doi.org/10.1079/phn2001139
[6] Hornyak, M., Voderholzer, U., Hohagen, F., Berger, M., Riemann, D. (1998). Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: An open pilot study. Sleep, 21(5), 501–505. https://doi.org/10.1093/sleep/21.5.501
[7] Aukerman, M. M., Aukerman, D., Bayard, M., Tudiver, F., Thorp, L., Bailey, B. (2006). Exercise and restless legs syndrome: A randomized controlled trial. Journal of the American Board of Family Medicine, 19(5), 487–493. https://doi.org/10.3122/jabfm.19.5.487
[8] Dzaja, A., Wehrle, R., Lancel, M., Pollmacher, T. (2009). Elevated estradiol plasma levels in women with restless legs during pregnancy. Sleep, 32(2), 169–174. https://doi.org/10.1093/sleep/32.2.169
Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.